 |
|
Anthony Man, Chief Executive Officer, MD, FRCP, was born in 1956, is a Swiss citizen
and holds an honor’s degree in biochemistry in addition to a medical
degree. He is an elected Fellow of the Royal College of Physicians
(UK). Dr. Man has over 20 years international pharmaceutical industry
experience and has developed numerous successful products particularly
in oncology. He has held a variety of senior positions spanning
pre-clinical development to registration and commercialization while at
Lederle, Roche, Ciba-Geigy AG, and Novartis AG. As Chief Development
Officer at Basilea from 2001 to 2003, he built up the drug development
organization and advanced all key development products through their
major milestones. In April 2003, Dr. Man was appointed as Chief
Executive Officer. |